首页> 美国卫生研究院文献>Biochemical Journal >X-ray-crystallographic studies of complexes of pepstatin A and a statine-containing human renin inhibitor with endothiapepsin.
【2h】

X-ray-crystallographic studies of complexes of pepstatin A and a statine-containing human renin inhibitor with endothiapepsin.

机译:胃酶抑素和胃蛋白酶抑制素与胃蛋白酶的复合物的X射线晶体学研究。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

H-189, a synthetic human renin inhibitor, and pepstatin A, a naturally occurring inhibitor of aspartic proteinases, have been co-crystallized with the fungal aspartic proteinase endothiapepsin (EC 3.4.23.6). H-189 [Pro-His-Pro-Phe-His-Sta-(statyl)-Val-Ile-His-Lys] is an analogue of human angiotensinogen. Pepstatin A [Iva(isovaleryl)-Val-Val-Sta-Ala-Sta] is a blocked pentapeptide which inhibits many aspartic proteinases. The structures of the complexes have been determined by X-ray diffraction and refined to crystallographic R-factors of 0.15 and 0.16 at resolutions of 0.18 nm (1.8 A) and 0.2 nm (2.0 A) respectively. H-189 is in an extended conformation, in which the statine residue is a dipeptide analogue of P1 and P'1 as indicated by the conformation and network of contacts and hydrogen bonds. Pepstatin A has an extended conformation to the P'2 alanine residue, but the leucyl side chain of the terminal statine residue binds back into the S'1 subsite, and an inverse gamma-turn occurs between P'1 and P'3. The hydroxy moiety of the statine at P1 in both complexes displaces the solvent molecule that hydrogen-bonds with the catalytic aspartate residues (32 and 215) in the native enzyme. Solvent molecules originally present in the native structure at the active site are displaced on inhibitor binding (12 when pepstatin A binds; 16 when H-189 binds).
机译:合成的人肾素抑制剂H-189和天冬氨酸蛋白酶的天然抑制剂pepstatin A已与真菌天冬氨酸蛋白酶内皮蛋白酶一起结晶(EC 3.4.23.6)。 H-189 [Pro-His-Pro-Phe-His-Sta-(statyl)-Val-Ile-His-Lys]是人类血管紧张素原的类似物。胃抑素A [Iva(异戊酰基)-Val-Val-Sta-Ala-Sta]是一种封闭的五肽,可抑制许多天冬氨酸蛋白酶。配合物的结构已通过X射线衍射测定,并分别以0.18 nm(1.8 A)和0.2 nm(2.0 A)的分辨率精制为0.15和0.16的晶体R因子。 H-189具有扩展构象,其中他汀类药物残基是P1和P'1的二肽类似物,如构象以及接触和氢键网络所示。胃抑素A对P'2丙氨酸残基具有扩展的构象,但末端他汀类药物残基的亮氨酰侧链结合回到S'1亚位点,并且在P'1和P'3之间发生反伽马转角。两种复合物中P1上他汀的羟基部分都取代了与天然酶中的催化天冬氨酸残基(32和215)氢键结合的溶剂分子。最初存在于活性位点天然结构中的溶剂分子在抑制剂结合时被置换(当胃蛋白酶抑制剂A结合时为12;当H-189结合时为16)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号